Recent studies have shown that BIRC5 should be regarded as a potential biomarker for molecular diagnosis and therapeutic intervention of HCC, and it exerts a significant effect on the prognosis of patients with HCC (18, 19). The gene discussed is BIRC5; the disease is hepatocellular carcinoma.